Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Top Cited Papers
Open Access
- 1 September 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (5), 1724-1732
- https://doi.org/10.1182/blood-2006-03-009910
Abstract
Using fluorescence in situ hybridization we investigated amplification of chromosome band 1q21 (Amp1q21) in more than 500 untreated patients with monoclonal gamKeywords
This publication has 55 references indexed in Scilit:
- Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321Journal of Clinical Oncology, 2006
- Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myelomaBlood, 2004
- The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersNature Medicine, 2004
- Treatment of multiple myelomaBlood, 2004
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomasOncogene, 2001
- DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcomaInternational Journal of Cancer, 1999
- Human and Mouse Chromosomal Mapping of the Myeloid Cell Leukemia-1 Gene: MCL1 Maps to Human Chromosome 1q21, a Region That Is Frequently Altered in Preneoplastic and Neoplastic DiseaseGenomics, 1994